CDF CEO, Marilyn Geller, will present the celiac patient voice at the May 11 FDA Patient-Focused Drug Development meeting. Have your voice be heard. Complete the CDF Celiac PFDD Survey now.
Celiac Disease Foundation Chief Executive Officer, Marilyn Geller, attended The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, D.C. The Summit explored the current trends in diagnosis, treatment, and therapies, presented by experts in research, environment, advocacy, and patient issues.
On March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington, D.C. This landmark conference addressed endpoints and outcome measures for trials for products intended to treat celiac disease and Irritable Bowel Disease. The second day […]
Celiac Disease Foundation is pleased to announce our participation in the Autoimmune Research Registry, known as ARNet. ARNet is a network of autoimmune disease advocacy organizations that will foster research into celiac disease and related autoimmune conditions. In consonance with CDF’s Strategic Plan to increase national awareness of the ramifications of undiagnosed celiac disease, the first goal of […]
On March 1 and 2, 2015, Talia Hassid, Celiac Disease Foundation’s Community Coordinator, attended the Digestive Disease National Coalition Public Policy Forum held in Washington DC. The forum gathers representatives from digestive disease organizations across the U.S. together to arrive at a common agenda to influence health care policy in the United States.
On March 23rd, join CDF at The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, DC. The summit will bring together leading experts in research, environment, advocacy and patient issues to explore the most current trends in autoimmune disease diagnosis, treatments and therapies.
Learn from experts from the Celiac Program at Harvard Medical School at the inaugural CEU-based medical and nutrition conference titled “Gluten Free for Life: A Comprehensive Toolkit for Diagnosing and Treating Celiac Disease and Other Gluten-Related Disorders” with separate healthcare professionals and patient tracks.
LOS ANGELES, Calif., Feb. 6, 2015 –Celiac Disease Foundation today sent a letter to California Attorney General Kamala Harris, asking that she issue notifications to GNC Holdings, Inc., Target Corporation, Walgreens and Wal-Mart Stores, Inc., to cease and desist engaging in the sale of adulterated and/or mislabeled herbal dietary supplements in California. “On behalf of the concerned California citizens […]
The Celiac Disease Foundation Medical Advisory Board, together with the National Board of Directors submitted a letter to the U.S. Preventive Services Task Force supporting the North American Society for the Study of Celiac Disease (NASSCD) comments on the Task Force’s draft research plan for screening for celiac disease. Among other comments, the NASSCD encouraged […]
Affecting 1% of the population, celiac disease is one of the world’s most prevalent genetic autoimmune conditions. In the United States, celiac disease is also one of the least diagnosed, with an estimated 2.5 million children and adults continuing to suffer needlessly. Long-term health complications of undiagnosed celiac disease include cancers, coronary heart disease, osteoporosis, […]